Loading…
The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery
Background/Aim Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and activated T cells. Its pleiotropic immune functions, such as bone remodeling, cancer progression, immune response, and inflammation have been reported...
Saved in:
Published in: | International journal of clinical oncology 2022-11, Vol.27 (11), p.1706-1716 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43 |
---|---|
cites | cdi_FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43 |
container_end_page | 1716 |
container_issue | 11 |
container_start_page | 1706 |
container_title | International journal of clinical oncology |
container_volume | 27 |
creator | Sekiguchi, Kumiko Matsuda, Akihisa Yamada, Marina Matsumoto, Satoshi Sakurazawa, Nobuyuki Kawano, Youichi Yamada, Takeshi Miyashita, Masao Yoshida, Hiroshi |
description | Background/Aim
Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and activated T cells. Its pleiotropic immune functions, such as bone remodeling, cancer progression, immune response, and inflammation have been reported previously. However, the association between OPN and postoperative complications (POC) after colorectal cancer (CRC) surgery has not been studied, so far.
Methods
Peripheral blood samples were collected before (pre) and immediately after surgery (post), and on postoperative days (POD) 1, 3, 5, and 7. Serum OPN levels were measured by ELISA. In total, 78 patients who underwent elective CRC surgery were divided into the No-POC (
n
= 54) and POC (
n
= 24) groups.
Results
The POC group had significantly higher OPN levels than the No-POC group throughout the postoperative observation period. The maximum OPN levels from pre- to postsurgical samples showed the best predictive potential for POCs (cut off: 20.75 ng/mL, area under the curve: 0.724) and were correlated with length of postoperative stays. OPN values were significantly correlated with C-reactive protein on POD3 and were identified as an independent predictive marker for POCs (odds ratio: 3.88, 95% CI: 1.175–12.798,
P
= 0.026). The severity of POCs was reflected in increased OPN levels.
Conclusion
Increased postoperative OPN was associated with increased postoperative inflammatory host responses and POC after CRC surgery. Serum OPN level may be a useful biomarker for early prediction of POC and it may provide additional information for treatment decisions to prevent POC. |
doi_str_mv | 10.1007/s10147-022-02225-6 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2701139434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2701139434</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43</originalsourceid><addsrcrecordid>eNp9kUtLxDAUhYso-PwDrgJu3FTzatIsRXzBgBtdhya9GTtkmpqkA_PvzTiC4MJFSO7hO4cbTlVdEnxDMJa3iWDCZY0p3R3a1OKgOiGcyVpKSQ_Lm3FSK0Gb4-o0pRXGRIqGnlTx7QPQnAc_5C0KDiWI8xqFlCFMYczDiDxswCfkQkRThH6wRVyiqSBhgtjlYQPIhvXkB1uGMCbUuQyxaD5EsLnzyHajLUqa4xLi9rw6cp1PcPFzn1Xvjw9v98_14vXp5f5uUVsmRa4ZGNkK13JBlOkBO9Jwo7oeOMUN4a2yLW2ZU4YJK5TBhprekKZ3jCrDLWdn1fU-d4rhc4aU9XpIFrzvRghz0lRiQpjibIde_UFXYY5j2U7TVmGOqeCkUHRP2RhSiuD0FId1F7eaYL2rQe9r0KUC_V2DFsXE9qZU4LH8_zf6H9cXGRCNBw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2890402641</pqid></control><display><type>article</type><title>The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery</title><source>Springer Link</source><creator>Sekiguchi, Kumiko ; Matsuda, Akihisa ; Yamada, Marina ; Matsumoto, Satoshi ; Sakurazawa, Nobuyuki ; Kawano, Youichi ; Yamada, Takeshi ; Miyashita, Masao ; Yoshida, Hiroshi</creator><creatorcontrib>Sekiguchi, Kumiko ; Matsuda, Akihisa ; Yamada, Marina ; Matsumoto, Satoshi ; Sakurazawa, Nobuyuki ; Kawano, Youichi ; Yamada, Takeshi ; Miyashita, Masao ; Yoshida, Hiroshi</creatorcontrib><description>Background/Aim
Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and activated T cells. Its pleiotropic immune functions, such as bone remodeling, cancer progression, immune response, and inflammation have been reported previously. However, the association between OPN and postoperative complications (POC) after colorectal cancer (CRC) surgery has not been studied, so far.
Methods
Peripheral blood samples were collected before (pre) and immediately after surgery (post), and on postoperative days (POD) 1, 3, 5, and 7. Serum OPN levels were measured by ELISA. In total, 78 patients who underwent elective CRC surgery were divided into the No-POC (
n
= 54) and POC (
n
= 24) groups.
Results
The POC group had significantly higher OPN levels than the No-POC group throughout the postoperative observation period. The maximum OPN levels from pre- to postsurgical samples showed the best predictive potential for POCs (cut off: 20.75 ng/mL, area under the curve: 0.724) and were correlated with length of postoperative stays. OPN values were significantly correlated with C-reactive protein on POD3 and were identified as an independent predictive marker for POCs (odds ratio: 3.88, 95% CI: 1.175–12.798,
P
= 0.026). The severity of POCs was reflected in increased OPN levels.
Conclusion
Increased postoperative OPN was associated with increased postoperative inflammatory host responses and POC after CRC surgery. Serum OPN level may be a useful biomarker for early prediction of POC and it may provide additional information for treatment decisions to prevent POC.</description><identifier>ISSN: 1341-9625</identifier><identifier>EISSN: 1437-7772</identifier><identifier>DOI: 10.1007/s10147-022-02225-6</identifier><language>eng</language><publisher>Singapore: Springer Nature Singapore</publisher><subject>Bone cancer ; Bone remodeling ; C-reactive protein ; Cancer Research ; Colorectal cancer ; Colorectal carcinoma ; Complications ; Inflammation ; Lymphocytes T ; Macrophages ; Medicine ; Medicine & Public Health ; Oncology ; Original Article ; Osteopontin ; Peripheral blood ; Postoperative ; Surgery ; Surgical Oncology</subject><ispartof>International journal of clinical oncology, 2022-11, Vol.27 (11), p.1706-1716</ispartof><rights>The Author(s) under exclusive licence to Japan Society of Clinical Oncology 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43</citedby><cites>FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43</cites><orcidid>0000-0002-6468-9375</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Sekiguchi, Kumiko</creatorcontrib><creatorcontrib>Matsuda, Akihisa</creatorcontrib><creatorcontrib>Yamada, Marina</creatorcontrib><creatorcontrib>Matsumoto, Satoshi</creatorcontrib><creatorcontrib>Sakurazawa, Nobuyuki</creatorcontrib><creatorcontrib>Kawano, Youichi</creatorcontrib><creatorcontrib>Yamada, Takeshi</creatorcontrib><creatorcontrib>Miyashita, Masao</creatorcontrib><creatorcontrib>Yoshida, Hiroshi</creatorcontrib><title>The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery</title><title>International journal of clinical oncology</title><addtitle>Int J Clin Oncol</addtitle><description>Background/Aim
Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and activated T cells. Its pleiotropic immune functions, such as bone remodeling, cancer progression, immune response, and inflammation have been reported previously. However, the association between OPN and postoperative complications (POC) after colorectal cancer (CRC) surgery has not been studied, so far.
Methods
Peripheral blood samples were collected before (pre) and immediately after surgery (post), and on postoperative days (POD) 1, 3, 5, and 7. Serum OPN levels were measured by ELISA. In total, 78 patients who underwent elective CRC surgery were divided into the No-POC (
n
= 54) and POC (
n
= 24) groups.
Results
The POC group had significantly higher OPN levels than the No-POC group throughout the postoperative observation period. The maximum OPN levels from pre- to postsurgical samples showed the best predictive potential for POCs (cut off: 20.75 ng/mL, area under the curve: 0.724) and were correlated with length of postoperative stays. OPN values were significantly correlated with C-reactive protein on POD3 and were identified as an independent predictive marker for POCs (odds ratio: 3.88, 95% CI: 1.175–12.798,
P
= 0.026). The severity of POCs was reflected in increased OPN levels.
Conclusion
Increased postoperative OPN was associated with increased postoperative inflammatory host responses and POC after CRC surgery. Serum OPN level may be a useful biomarker for early prediction of POC and it may provide additional information for treatment decisions to prevent POC.</description><subject>Bone cancer</subject><subject>Bone remodeling</subject><subject>C-reactive protein</subject><subject>Cancer Research</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Complications</subject><subject>Inflammation</subject><subject>Lymphocytes T</subject><subject>Macrophages</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Osteopontin</subject><subject>Peripheral blood</subject><subject>Postoperative</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><issn>1341-9625</issn><issn>1437-7772</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUtLxDAUhYso-PwDrgJu3FTzatIsRXzBgBtdhya9GTtkmpqkA_PvzTiC4MJFSO7hO4cbTlVdEnxDMJa3iWDCZY0p3R3a1OKgOiGcyVpKSQ_Lm3FSK0Gb4-o0pRXGRIqGnlTx7QPQnAc_5C0KDiWI8xqFlCFMYczDiDxswCfkQkRThH6wRVyiqSBhgtjlYQPIhvXkB1uGMCbUuQyxaD5EsLnzyHajLUqa4xLi9rw6cp1PcPFzn1Xvjw9v98_14vXp5f5uUVsmRa4ZGNkK13JBlOkBO9Jwo7oeOMUN4a2yLW2ZU4YJK5TBhprekKZ3jCrDLWdn1fU-d4rhc4aU9XpIFrzvRghz0lRiQpjibIde_UFXYY5j2U7TVmGOqeCkUHRP2RhSiuD0FId1F7eaYL2rQe9r0KUC_V2DFsXE9qZU4LH8_zf6H9cXGRCNBw</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Sekiguchi, Kumiko</creator><creator>Matsuda, Akihisa</creator><creator>Yamada, Marina</creator><creator>Matsumoto, Satoshi</creator><creator>Sakurazawa, Nobuyuki</creator><creator>Kawano, Youichi</creator><creator>Yamada, Takeshi</creator><creator>Miyashita, Masao</creator><creator>Yoshida, Hiroshi</creator><general>Springer Nature Singapore</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6468-9375</orcidid></search><sort><creationdate>20221101</creationdate><title>The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery</title><author>Sekiguchi, Kumiko ; Matsuda, Akihisa ; Yamada, Marina ; Matsumoto, Satoshi ; Sakurazawa, Nobuyuki ; Kawano, Youichi ; Yamada, Takeshi ; Miyashita, Masao ; Yoshida, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bone cancer</topic><topic>Bone remodeling</topic><topic>C-reactive protein</topic><topic>Cancer Research</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Complications</topic><topic>Inflammation</topic><topic>Lymphocytes T</topic><topic>Macrophages</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Osteopontin</topic><topic>Peripheral blood</topic><topic>Postoperative</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sekiguchi, Kumiko</creatorcontrib><creatorcontrib>Matsuda, Akihisa</creatorcontrib><creatorcontrib>Yamada, Marina</creatorcontrib><creatorcontrib>Matsumoto, Satoshi</creatorcontrib><creatorcontrib>Sakurazawa, Nobuyuki</creatorcontrib><creatorcontrib>Kawano, Youichi</creatorcontrib><creatorcontrib>Yamada, Takeshi</creatorcontrib><creatorcontrib>Miyashita, Masao</creatorcontrib><creatorcontrib>Yoshida, Hiroshi</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest - Health & Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sekiguchi, Kumiko</au><au>Matsuda, Akihisa</au><au>Yamada, Marina</au><au>Matsumoto, Satoshi</au><au>Sakurazawa, Nobuyuki</au><au>Kawano, Youichi</au><au>Yamada, Takeshi</au><au>Miyashita, Masao</au><au>Yoshida, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery</atitle><jtitle>International journal of clinical oncology</jtitle><stitle>Int J Clin Oncol</stitle><date>2022-11-01</date><risdate>2022</risdate><volume>27</volume><issue>11</issue><spage>1706</spage><epage>1716</epage><pages>1706-1716</pages><issn>1341-9625</issn><eissn>1437-7772</eissn><abstract>Background/Aim
Osteopontin (OPN) is a secretory glycoprotein, which is expressed not only in osteoblasts, but immune cells including macrophages and activated T cells. Its pleiotropic immune functions, such as bone remodeling, cancer progression, immune response, and inflammation have been reported previously. However, the association between OPN and postoperative complications (POC) after colorectal cancer (CRC) surgery has not been studied, so far.
Methods
Peripheral blood samples were collected before (pre) and immediately after surgery (post), and on postoperative days (POD) 1, 3, 5, and 7. Serum OPN levels were measured by ELISA. In total, 78 patients who underwent elective CRC surgery were divided into the No-POC (
n
= 54) and POC (
n
= 24) groups.
Results
The POC group had significantly higher OPN levels than the No-POC group throughout the postoperative observation period. The maximum OPN levels from pre- to postsurgical samples showed the best predictive potential for POCs (cut off: 20.75 ng/mL, area under the curve: 0.724) and were correlated with length of postoperative stays. OPN values were significantly correlated with C-reactive protein on POD3 and were identified as an independent predictive marker for POCs (odds ratio: 3.88, 95% CI: 1.175–12.798,
P
= 0.026). The severity of POCs was reflected in increased OPN levels.
Conclusion
Increased postoperative OPN was associated with increased postoperative inflammatory host responses and POC after CRC surgery. Serum OPN level may be a useful biomarker for early prediction of POC and it may provide additional information for treatment decisions to prevent POC.</abstract><cop>Singapore</cop><pub>Springer Nature Singapore</pub><doi>10.1007/s10147-022-02225-6</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-6468-9375</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1341-9625 |
ispartof | International journal of clinical oncology, 2022-11, Vol.27 (11), p.1706-1716 |
issn | 1341-9625 1437-7772 |
language | eng |
recordid | cdi_proquest_miscellaneous_2701139434 |
source | Springer Link |
subjects | Bone cancer Bone remodeling C-reactive protein Cancer Research Colorectal cancer Colorectal carcinoma Complications Inflammation Lymphocytes T Macrophages Medicine Medicine & Public Health Oncology Original Article Osteopontin Peripheral blood Postoperative Surgery Surgical Oncology |
title | The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A15%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20utility%20of%20serum%20osteopontin%20levels%20for%20predicting%20postoperative%20complications%20after%20colorectal%20cancer%20surgery&rft.jtitle=International%20journal%20of%20clinical%20oncology&rft.au=Sekiguchi,%20Kumiko&rft.date=2022-11-01&rft.volume=27&rft.issue=11&rft.spage=1706&rft.epage=1716&rft.pages=1706-1716&rft.issn=1341-9625&rft.eissn=1437-7772&rft_id=info:doi/10.1007/s10147-022-02225-6&rft_dat=%3Cproquest_cross%3E2701139434%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c376t-3eb786f84619bde0f154b9ade42051489c8283f9b36c69b0b2bdb15df329b4c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2890402641&rft_id=info:pmid/&rfr_iscdi=true |